Company intelligence / Profile preview

Cent Cure

Baddi, Himachal Pradesh, India

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Cent Cure is an Indian pharmaceutical contract manufacturing company (CMO) established in 2018 and based in Baddi, Himachal Pradesh. The company operates a WHO-GMP and GLP-certified manufacturing facility, specializing in third-party manufacturing of a wide range of pharmaceutical formulations, including tablets, capsules, ointments, lotions, and sachets. Cent Cure's product portfolio spans multiple therapeutic categories such as antibiotics, anti-inflammatories, cardiovascular medicines, gastrointestinal treatments, and multivitamins. The company provides end-to-end contract manufacturing services, regulatory support, and packaging solutions to pharmaceutical brands across India.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Cent Cure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cent Cure.

Explore the full profile